Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue. The pharmaceutical giant said Monday it will pay $229 ...

Pfizer will close its $43 billion takeover of Bothell-based Seagen as the pharma giant shifts away from its fading COVID-19 business to go deeper into pharma’s most lucrative field, oncology. Pfizer ...

Pfizer is spending about $43 billion to acquire Seagen, the Bothell-based biotech giant formerly known as Seattle Genetics. Pfizer plans to let the cancer treatment developer “continue innovating,” ...

BOTHELL — Clay Siegall, the former CEO of Seagen who resigned last year over allegations of domestic abuse, will return to the area as chief executive of Immunome, a Pennsylvania-based biotech company ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The pharmaceutical giant, which ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The move, affecting nearly 7% of ...

FILE - A man walks by Pfizer headquarters, Friday, Feb. 5, 2021, in New York. Pfizer will spend about $43 billion to buy Seagen and broaden its reach into cancer treatments, the pharmaceutical giant ...